Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Regul Toxicol Pharmacol ; 69(2): 187-200, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24680767

RESUMO

The development path described for JNJ-26489112 provides perspectives on interpretation of retinal effects observed in nonclinical studies and their implications for clinical development. JNJ-26489112 is a CNS-active investigational drug that has potential as a novel treatment for treatment-resistant and bipolar depression, epilepsy, and neuropathic/inflammatory pain. In a 6-month toxicity study in albino rats, retinal atrophy was observed at supratherapeutic exposures to JNJ-26489112. The histopathological changes and topography of the lesions were characteristic of light-induced damage specific to albino rats. The species/strain specificity is supported by an absence of any ocular effects in dogs and in pigmented and albino rats, housed under standard and reduced lighting, respectively. To further evaluate its potential to cause ocular effects, in vivo functional and structural ocular analyses were included in a 9-month monkey toxicity study. Reductions in rod- and cone-mediated electroretinograms were observed at supratherapeutic exposures but without any histopathologic changes. These data suggested that the effects of JNJ-26489112 in monkeys were neuromodulatory and not neurotoxic. Taken together, data related to the light-induced atrophy in albino rats and reversible neuromodulatory effects in monkeys, supported the safe evaluation of JNJ-26489112 in a clinical proof-of-concept study that included comprehensive functional and structural ocular monitoring.


Assuntos
Fármacos do Sistema Nervoso Central/toxicidade , Dioxanos/toxicidade , Retina/efeitos dos fármacos , Retina/patologia , Doenças Retinianas/induzido quimicamente , Sulfonamidas/toxicidade , Administração Oral , Animais , Fármacos do Sistema Nervoso Central/administração & dosagem , Fármacos do Sistema Nervoso Central/química , Dioxanos/administração & dosagem , Dioxanos/química , Cães , Eletrorretinografia , Feminino , Luz , Macaca fascicularis , Masculino , Conformação Molecular , Ratos , Ratos Sprague-Dawley , Doenças Retinianas/patologia , Sulfonamidas/administração & dosagem , Sulfonamidas/química
2.
Br J Nutr ; 90(6): 1007-14, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14641959

RESUMO

An increased protein content and less digestible protein sources in the diet can induce bad faecal odour. The present study investigated the effect of adding prebiotics to dog diets enriched with animal-derived protein sources on apparent digestibilities and faecal ammonia concentration. In three subsequent periods eight healthy beagle dogs were fed a commercial dog diet that was gradually supplemented by up to 50 % with meat and bone meal (MBM), greaves meal (GM) or poultry meal (PM) respectively. Afterwards, 3 % fructo-oligosaccharides or 3 % isomalto-oligosaccharides were substituted for 3 % of the total diet. Supplementation with animal-derived protein sources did not decrease the apparent N digestibility significantly but oligosaccharides did. On the other hand the bacterial N content (% DM) in the faeces was highest in the oligosaccharide groups followed by the protein-supplemented groups and lowest in the control groups. When the apparent N digestibility was corrected for bacterial N no significant differences were noted anymore except for the GM group where the corrected N digestibility was still lower after oligosaccharide supplementation. The amount of faecal ammonia was significantly increased by supplementing with protein or oligosaccharides in the MBM and GM groups but not in the PM group. When apparent N digestibility is interpreted, a correction for bacterial N should be taken into account, especially when prebiotics are added to the diet. Oligosaccharides did not reduce the faecal ammonia concentrations as expected.


Assuntos
Amônia/metabolismo , Proteínas Alimentares/administração & dosagem , Suplementos Nutricionais , Digestão/efeitos dos fármacos , Cães/metabolismo , Ração Animal , Fenômenos Fisiológicos da Nutrição Animal , Animais , Bactérias/metabolismo , Dieta/veterinária , Fezes/química , Fezes/microbiologia , Concentração de Íons de Hidrogênio/efeitos dos fármacos , Nitrogênio/metabolismo , Odorantes/prevenção & controle , Oligossacarídeos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...